Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 80.55 | 74.38 | 89.70 | 100.11 | 64.77 | 54.13 | 55.79 | 66.85 | 69.03 | 64.77 | — | 199.27 | 45.57 | 262.95 | 179.20 | 316.69 | 557.82 | — | — | 27766.25 | — |
| — | +37.4% | +60.8% | +49.8% | -6.2% | -16.4% | — | -66.5% | +51.5% | -75.4% | — | -37.1% | -91.8% | — | — | -98.9% | — | — | — | +13035.0% | — | |
| P/S Ratio | 8.05 | 7.69 | 8.01 | 8.66 | 7.95 | 7.02 | 7.42 | 8.08 | 7.39 | 6.32 | 5.83 | 7.89 | 8.68 | 8.75 | 12.89 | 11.28 | 9.78 | 8.41 | 5.64 | 10.54 | 13.19 |
| — | +9.6% | +8.0% | +7.2% | +7.5% | +11.0% | +27.2% | +2.4% | -14.9% | -27.8% | -54.8% | -30.1% | -11.2% | +4.1% | +128.5% | +7.0% | -25.8% | -36.2% | -59.6% | -29.7% | +34.3% | |
| P/B Ratio | 8.79 | 7.97 | 8.16 | 8.81 | 8.58 | 7.33 | 7.78 | 8.63 | 8.10 | 6.89 | 6.01 | 7.30 | 8.38 | 8.59 | 12.65 | 10.63 | 8.66 | 7.38 | 4.85 | 8.96 | 11.28 |
| — | +8.7% | +4.9% | +2.0% | +5.9% | +6.3% | +29.5% | +18.2% | -3.3% | -19.8% | -52.5% | -31.3% | -3.2% | +16.4% | +160.8% | +18.6% | -23.2% | -49.6% | -68.3% | -42.6% | +9.8% | |
| P/FCF | 62.68 | 119.43 | 95.99 | 44.29 | 44.99 | 59.24 | 85.74 | 73.74 | 50.97 | 37.31 | 96.56 | 67.68 | 75.75 | 86.21 | 264.32 | 294.80 | — | — | — | — | — |
| — | +101.6% | +12.0% | -39.9% | -11.7% | +58.8% | -11.2% | +9.0% | -32.7% | -56.7% | -63.5% | -77.0% | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 60.12 | 55.90 | 67.00 | 75.69 | 48.20 | 47.99 | 53.26 | 56.86 | 48.90 | 47.83 | — | 112.12 | 59.13 | 122.91 | 138.26 | 189.07 | 195.56 | 157.65 | 210.04 | 1301.96 | — |
| — | +16.5% | +25.8% | +33.1% | -1.4% | +0.3% | — | -49.3% | -17.3% | -61.1% | — | -40.7% | -69.8% | -22.0% | -34.2% | -85.5% | — | -22.7% | +12.6% | +766.6% | — | |
| EV / EBIT | 66.51 | 55.49 | 67.22 | 77.13 | 48.00 | 46.77 | 54.08 | 58.38 | 51.62 | 47.11 | — | 146.38 | 100.91 | 77.95 | 170.23 | 344.30 | 456.18 | 338.24 | — | — | — |
| — | +18.6% | +24.3% | +32.1% | -7.0% | -0.7% | — | -60.1% | -48.8% | -39.6% | — | -57.5% | -77.9% | -77.0% | — | — | — | +17.3% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 68.3% | 67.9% | 67.6% | 68.0% | 67.8% | 66.0% | 66.6% | 66.8% | 66.5% | 54.4% | 65.0% | 65.7% | 65.6% | 63.8% | 62.6% | 62.6% | 63.3% | 64.3% | 62.5% | 61.5% |
| — | +0.8% | +2.9% | +1.5% | +1.8% | +1.9% | +21.3% | +2.5% | +1.7% | +1.4% | -14.8% | +3.9% | +5.0% | +3.6% | -0.8% | +0.1% | +1.8% | +0.4% | -0.1% | -5.0% | +8.8% | |
| Operating Margin | 13.5% | 12.4% | 10.5% | 10.2% | 15.4% | 13.8% | 12.0% | 12.4% | 13.6% | 11.7% | -27.0% | 4.3% | 12.3% | 4.7% | 6.8% | 3.3% | 2.2% | 2.5% | -0.1% | -2.0% | -19.6% |
| — | -10.2% | -12.5% | -18.0% | +13.4% | +17.2% | +144.5% | +186.7% | +10.2% | +152.1% | -495.3% | +30.9% | +463.2% | +83.2% | +10356.2% | +267.2% | +111.1% | -44.9% | -101.2% | -124.9% | -1778.0% | |
| Net Margin | 12.7% | 10.3% | 8.9% | 8.7% | 12.3% | 12.9% | 13.3% | 12.1% | 10.7% | 9.8% | -20.1% | 3.9% | 19.0% | 3.4% | 7.3% | 3.5% | 1.8% | -1.1% | -1.8% | 0.0% | -12.1% |
| — | -20.3% | -33.1% | -28.1% | +15.1% | +31.8% | +166.3% | +206.5% | -43.9% | +188.4% | -377.3% | +11.3% | +986.7% | +420.0% | +509.7% | +9064.9% | +114.5% | -122.8% | -135.3% | -99.4% | -652.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 13.8% | 2.7% | 2.3% | 2.2% | 3.4% | 3.5% | 3.6% | 3.3% | 3.0% | 2.6% | -5.1% | 0.9% | 4.7% | 0.8% | 1.8% | 0.8% | 0.4% | -0.2% | -0.4% | 0.0% | -3.0% |
| — | -21.5% | -35.8% | -32.3% | +13.8% | +32.6% | +170.9% | +259.3% | -37.1% | +207.0% | -380.7% | +9.1% | +1108.2% | +463.3% | +574.5% | +10096.4% | +113.1% | -117.9% | -127.4% | -99.5% | -618.2% | |
| ROA | 10.6% | 2.1% | 1.8% | 1.7% | 2.7% | 2.7% | 2.8% | 2.5% | 2.2% | 2.0% | -3.9% | 0.7% | 3.6% | 0.6% | 1.3% | 0.6% | 0.3% | -0.2% | -0.3% | 0.0% | -2.2% |
| — | -21.2% | -35.1% | -30.3% | +18.6% | +36.9% | +171.7% | +257.6% | -37.6% | +208.5% | -388.3% | +13.3% | +1144.8% | +470.6% | +578.2% | +9883.9% | +113.0% | -118.2% | -126.6% | -99.6% | -597.4% | |
| ROIC | 11.3% | 2.5% | 2.1% | 2.0% | 3.3% | 3.1% | 2.8% | 2.9% | 3.1% | 2.5% | -5.2% | 0.7% | 2.1% | 0.8% | 1.1% | 0.5% | 0.3% | 0.4% | -0.0% | -0.3% | -3.2% |
| — | -20.7% | -27.6% | -31.4% | +7.1% | +26.6% | +154.3% | +288.8% | +44.1% | +214.4% | -559.1% | +43.1% | +573.1% | +118.1% | +12393.5% | +285.2% | +109.8% | -58.7% | -100.8% | -118.2% | -1458.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.13 | 0.14 | 0.15 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.20 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.22 | 0.23 | 0.23 | 0.18 |
| — | -17.2% | -18.5% | -19.4% | -20.7% | -22.2% | -13.5% | -5.4% | -2.4% | -0.9% | -9.1% | -15.6% | -15.8% | -7.2% | -4.4% | -0.1% | +29.7% | -12.2% | +18.4% | +93.4% | +50.2% | |
| Debt / EBITDA | 1.06 | 3.73 | 4.56 | 5.05 | 3.45 | 4.23 | 4.76 | 4.86 | 4.74 | 5.74 | — | 11.80 | 5.57 | 11.70 | 9.40 | 16.01 | 20.91 | 18.66 | 37.98 | 130.35 | — |
| — | -11.9% | -4.2% | +3.8% | -27.2% | -26.3% | — | -58.8% | -15.0% | -51.0% | — | -26.3% | -73.4% | -37.3% | -75.2% | -87.7% | — | +33.0% | +308.3% | +2774.8% | — | |
| Current Ratio | 6.64 | 5.89 | 5.75 | 6.02 | 6.64 | 6.73 | 6.75 | 6.30 | 6.01 | 5.82 | 6.25 | 6.12 | 6.06 | 5.99 | 5.74 | 5.37 | 5.21 | 5.23 | 4.93 | 5.31 | 5.53 |
| — | -12.5% | -14.9% | -4.4% | +10.6% | +15.6% | +8.1% | +3.0% | -0.8% | -2.8% | +8.8% | +13.8% | +16.2% | +14.4% | +16.5% | +1.3% | -5.7% | -9.1% | -18.4% | -6.5% | -5.1% | |
| Quick Ratio | 4.29 | 3.92 | 3.86 | 3.95 | 4.29 | 4.18 | 4.04 | 3.68 | 3.44 | 3.25 | 3.77 | 3.51 | 3.49 | 3.41 | 3.25 | 3.02 | 2.91 | 2.92 | 2.90 | 3.20 | 3.39 |
| — | -6.1% | -4.6% | +7.4% | +24.7% | +28.5% | +7.1% | +4.8% | -1.5% | -4.5% | +16.0% | +16.2% | +19.9% | +16.8% | +12.3% | -5.4% | -14.2% | -17.4% | -21.3% | -8.2% | -9.7% | |
| Interest Coverage | 157.46 | 185.64 | 149.51 | 132.51 | 192.09 | 155.81 | 143.04 | 137.20 | 132.57 | 119.39 | -225.38 | 37.47 | — | — | 45.00 | — | — | 126.37 | -1.93 | -86.09 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PEN stock.
Penumbra, Inc.'s current P/E is 80.5x. The average P/E over the last 4 quarters is 82.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Penumbra, Inc.'s current operating margin is 13.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Penumbra, Inc.'s business trajectory between earnings reports.